Dupuytren’s Contracture Market Making CAGR of 4.4% by 2023 with Global Organizations Like Bristol-Meyers Squibb Co, Merck & Company, Pfizer Inc. and More

Global Dupuytren’s Contracture Market – Segmentation

The Global Dupuytren’s Contracture Market has been segmented on the basis of types, diagnosis, surgery, drugs, therapy and end users. Based on type, the market has been segmented as type I, type II, type III. Based on diagnosis, the market has been segmented as physical examination, x-ray and others. Based on drug, the market has been segmented as steroids, collagenase injection, immune-modulators and others. Based on therapy, the market has been segmented as radiation therapy, physiotherapy and others. Based on the end user, the market has been segmented as hospitals & clinics, academic and research and others.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4401 .

Global Dupuytren’s Contracture Market – Dominant Players

Key players profiled in the report are Bristol-Meyers Squibb Co, Fresenius Kabi, Merck & Company, Pfizer Inc., West-Ward Pharmaceuticals, Spear Pharmaceuticals, Actiza Pharmaceutical Private Limited, Nantong Jinghua Pharmaceutical Co., Ltd., Endo International plc. Pfizer Inc., and others.

Global Dupuytren’s Contracture Market – Intended Audience

Global Dupuytren’s contracture treatment manufacturers & suppliers
Research and development (R&D) companies
Hospitals and clinics
Academic institutes and universities

Global Dupuytren’s Contracture Market – Market Highlights

Dupuytren's contracture is a condition in which there is difficulty in articulating fingers due to formation of tissue knots under the skin. In severe conditions, the fingers become permanently bent in a flexed position. Dupuytren's contracture is typically not painful and generally affects the ring finger followed by the little and middle fingers. The exact causes of Dupuytren's contracture are unknown, however, the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. Dupuytren's contracture has a higher rate in males over the age of 50. There is also a genetic propensity with Caucasians being affected more while it is rare among Asians and Africans. Dupuytren's contracture has a regress rate of approximately 10% of patients. The less severe forms of the disease are treated with steroid treatment and physiotherapy while surgery is usually performed when the metacarpophalangeal joint contracture exceeds 40 degrees or when the proximal interphalangeal joint contracture exceeds 20 degrees.

The annual incidence proportion was estimated at about 3 cases per 10,000 adults. The occurrence rate of this condition in the United States is about 5% of people, while Scandinavian nations have a higher rate of about 30% of men over 60 years old having the condition.

The market drivers for Dupuytren’s contracture market are, increase in risk factors rising incomes, growing screening, increasing geriatric population etc. The market restraints are cost of Dupuytren’s contracture surgery, complications and risk of the surgery, invasive nature of treatment, and regression of the disease even after treatment etc.

The Global Dupuytren’s Contracture Market is expected to reach USD 5.5 billion by 2023, and the market is projected to grow at a CAGR of ~ 4.4 % during the forecast period 2017-2023.

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/4401 .

Global Dupuytren’s Contracture Market – Regional Analysis

Europe account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the greater prevalence of Dupuytren’s contracture in Europe drives the Dupuytren’s contracture market. Also, concentration of major research companies in the developed countries of this region is adding fuel to the market growth. The highly developed healthcare system of the Scandavanian region coupled with high expenditure on healthcare, cruises the sale of Dupuytren’s contracture treatment. Europe is led by countries such as Germany and France. Norway is expected to be the fastest growing market.

US is the second largest market in the world due to high income and healthcare penetration. The presence of large healthcare players in the US benefits the market coupled with the high public expenditure on healthcare which comes to be approximately 16 % of the GDP. Asia Pacific region is expected to grow at a slower rate with China and India are likely to lead this market due to fast growing healthcare sector during the forecast period. The lower prevalence of Dupuytren’s contracture in the Asian populations acts as a drag on the market.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The development of large hospitals such as the King Fahd hospital in Riyadh is driving the market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development. Also the lower prevalence of Dupuytren’s contracture in the Asian populations acts as a drag on the market.

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued….

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/4401 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.